1. Pink Sheet
  2. >>Agency Leadership
  3. >>US FDA

FDA’s Awkward Transition Continues

 
• By Michael McCaughan

US FDA’s apolitical leadership team is highly unusual – but is it a strength or a weakness in a new Administration? Acting Commissioner Janet Woodcock has been running the agency for nearly six months and there are no signs of the status quo changing any time soon.

IS THE PROGRESS BAR STUCK ON THE BIDEN ADMINISTRATION TRANSITION AT FDA? • Source: Illustration

As Janet Woodcock approaches six months on the job as acting Commissioner of the US Food & Drug Administration, the agency continues in an unprecedented leadership position amid the transition to a new Presidency.

On the one hand, Woodcock is (or was?) President Joe Biden’s first choice to run the agency, and – despite headlines and speculations about other potential candidates – no one...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from US FDA

More from Agency Leadership